Orion Pharma (DHA:ORIONPHARM) Research & Development : BDT0 Mil (TTM As of Dec. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Orion Pharma Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Orion Pharma's Research & Development for the three months ended in Dec. 2023 was BDT0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was BDT0 Mil.

Orion Pharma Research & Development Historical Data

The historical data trend for Orion Pharma's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orion Pharma Research & Development Chart

Orion Pharma Annual Data

Trend

Dec13

Dec14

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Research & Development

Get a 7-Day Free Trial

2.24

2.35

4.28

4.54

3.15

Orion Pharma Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Research & Development	Get a 7-Day Free Trial															-	-	-	-	-

Orion Pharma Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT0 Mil.

Orion Pharma (DHA:ORIONPHARM) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Orion Pharma Research & Development Related Terms

Thank you for viewing the detailed overview of Orion Pharma's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Orion Pharma (DHA:ORIONPHARM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Utilities » Utilities - Independent Power Producers » Orion Pharma Ltd (DHA:ORIONPHARM) » Definitions » Research & Development

Traded in Other Exchanges

N/A

Address

153-154 Tejgaon Industrial Area, Dhaka, BGD, 1208

Website

https://www.orionpharmabd.com

Orion Pharma Ltd is a pharmaceutical company engaged in the manufacturing and marketing of pharmaceutical drugs and medicines. It provides its drugs in various dosage forms including tablet, capsule, syrup, suspension, injection, dry powder for syrup and suspension, for therapeutic groups like anticancer, antibiotics, antidiabetics, anxiolytics, diuretics, cardiovascular drugs, and others. In addition, the company is also involved in power generation activities. It generates maximum revenue from power generation activities. The group principally carries out its business operations and markets its products in Bangladesh.

Orion Pharma (DHA:ORIONPHARM) Headlines

No Headlines